Could neoadjuvant chemotherapy increase postoperative complication risk of laparoscopic total gastrectomy? A mono-institutional propensity score-matched study in China

Table 6 Univariate and multivariate logistic regression analyses for postoperative complications in laparoscopic total gastrectomy patients

Factor	Univariate analysis		P value	Multivariate analysis		P value
	OR	95%CI		OR	95%CI
Sex			0.221			0.076
Male	Ref			Ref
Female	1.807	0.700-4.666		2.601	0.906-7.465
Age			0.215			0.159
< 60	Ref			Ref
≥ 60	0.574	0.239-1.380		0.519	0.208-1.292
BMI (kg/m2)			0.596
< 25	Ref
≥ 25	1.277	0.517-3.152
Neoadjuvant chemotherapy			0.275
No	Ref
Yes	1.629	0.678-3.913
ASA score			0.723
< II	Ref
≥ II	1.474	0.173-12.538
Tumor diameter (cm)			0.208			0.139
< 5	Ref			Ref
≥ 5	1.747	0.733-4.162		2.049	0.793-5.296
Operation time (min)			0.031			0.024
< 240	Ref			Ref
≥ 240	2.726	1.093-6.799		3.021	1.160-7.868
Estimated blood loss (mL)			0.267
≤ 200	Ref
> 200	1.750	0.652-4.699
Vascular invasion			0.539
No	Ref
Yes	1.328	0.537-3.283
Nerve invasion			0.338
No	Ref
Yes	1.533	0.639-3.677

CI: Confidence interval; OR: Odds ratio; BMI: Body mass index; ASA: American Society of Anesthesiologists.